{"id": "article-19395_0", "title": "Cheyne Stokes Respirations -- Continuing Education Activity", "content": "Cheyne-Stokes respiration is a type of breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Despite increasing recognition and growing knowledge, Cheyne-Stokes respiration remains elusive, and patients have very limited treatment options. This activity highlights the role of the interprofessional team in caring for patients with Cheyne Stokes respiration.", "contents": "Cheyne Stokes Respirations -- Continuing Education Activity. Cheyne-Stokes respiration is a type of breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Despite increasing recognition and growing knowledge, Cheyne-Stokes respiration remains elusive, and patients have very limited treatment options. This activity highlights the role of the interprofessional team in caring for patients with Cheyne Stokes respiration."}
{"id": "article-19395_1", "title": "Cheyne Stokes Respirations -- Continuing Education Activity", "content": "Objectives: Review the etiology of Cheyne-Stokes breathing. Identify the clinical features of Cheyne-Stokes breathing. Summarize the evaluation of a patient with Cheyne-Stokes breathing. Describe the role of the interprofessional team in caring for patients with Cheyne-Stokes respiration. Access free multiple choice questions on this topic.", "contents": "Cheyne Stokes Respirations -- Continuing Education Activity. Objectives: Review the etiology of Cheyne-Stokes breathing. Identify the clinical features of Cheyne-Stokes breathing. Summarize the evaluation of a patient with Cheyne-Stokes breathing. Describe the role of the interprofessional team in caring for patients with Cheyne-Stokes respiration. Access free multiple choice questions on this topic."}
{"id": "article-19395_2", "title": "Cheyne Stokes Respirations -- Introduction", "content": "Cheyne-Stokes respiration is a type of\u00a0breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Unlike obstructive sleep apnea (OSA), which can be the cause of heart failure, Cheyne-Stokes respiration\u00a0is believed to be a result of heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure also predicts worse outcomes and increases the risk of sudden cardiac death. Despite increasing recognition and growing knowledge,\u00a0Cheyne-Stokes respiration\u00a0remains elusive, and patients have very limited treatment options. [1] [2] [3] [4]", "contents": "Cheyne Stokes Respirations -- Introduction. Cheyne-Stokes respiration is a type of\u00a0breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Unlike obstructive sleep apnea (OSA), which can be the cause of heart failure, Cheyne-Stokes respiration\u00a0is believed to be a result of heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure also predicts worse outcomes and increases the risk of sudden cardiac death. Despite increasing recognition and growing knowledge,\u00a0Cheyne-Stokes respiration\u00a0remains elusive, and patients have very limited treatment options. [1] [2] [3] [4]"}
{"id": "article-19395_3", "title": "Cheyne Stokes Respirations -- Etiology", "content": "Cheyne-Stokes respiration\u00a0is a specific form of periodic breathing (waxing and waning amplitude of flow or tidal volume) characterized by a crescendo-decrescendo pattern of respiration between central apneas or central hypopneas. The American Academy of Sleep Medicine (AASM) recommends to score a respiratory event as Cheyne-Stokes breathing if both of the following criteria are met: There are episodes of at least three consecutive central apneas and/or central hypopneas separated by a crescendo and decrescendo change in breathing amplitude with a cycle length of at least 40 seconds (typically 45 to 90 seconds). There are five or more central apneas and/or central hypopneas per hour associated with the crescendo/decrescendo breathing pattern recorded over a minimum of two hours of monitoring.", "contents": "Cheyne Stokes Respirations -- Etiology. Cheyne-Stokes respiration\u00a0is a specific form of periodic breathing (waxing and waning amplitude of flow or tidal volume) characterized by a crescendo-decrescendo pattern of respiration between central apneas or central hypopneas. The American Academy of Sleep Medicine (AASM) recommends to score a respiratory event as Cheyne-Stokes breathing if both of the following criteria are met: There are episodes of at least three consecutive central apneas and/or central hypopneas separated by a crescendo and decrescendo change in breathing amplitude with a cycle length of at least 40 seconds (typically 45 to 90 seconds). There are five or more central apneas and/or central hypopneas per hour associated with the crescendo/decrescendo breathing pattern recorded over a minimum of two hours of monitoring."}
{"id": "article-19395_4", "title": "Cheyne Stokes Respirations -- Etiology", "content": "Cheyne-Stokes respiration\u00a0should be differentiated from other central sleep apneas like idiopathic central sleep apnea wherein there is no waxing and the waning pattern of ventilation. The ventilation length in patients with\u00a0Cheyne-Stokes respiration\u00a0is more than 40 seconds compared to less than 40 seconds in central sleep apnea. Also, the relative duration of hyperventilation is more than apnea duration in\u00a0Cheyne-Stokes respiration. In central apneas, the duration of apnea is more than the duration of hyperventilation.", "contents": "Cheyne Stokes Respirations -- Etiology. Cheyne-Stokes respiration\u00a0should be differentiated from other central sleep apneas like idiopathic central sleep apnea wherein there is no waxing and the waning pattern of ventilation. The ventilation length in patients with\u00a0Cheyne-Stokes respiration\u00a0is more than 40 seconds compared to less than 40 seconds in central sleep apnea. Also, the relative duration of hyperventilation is more than apnea duration in\u00a0Cheyne-Stokes respiration. In central apneas, the duration of apnea is more than the duration of hyperventilation."}
{"id": "article-19395_5", "title": "Cheyne Stokes Respirations -- Etiology", "content": "Cheyne-Stokes respiration\u00a0is well-studied in patients with heart failure and stroke. In patients with heart failure, male gender, older age, sedentary lifestyle, diagnosis of atrial fibrillation, increased ventricular filling pressure, and more advanced cardiac remodeling are known to\u00a0predispose to\u00a0Cheyne-Stokes respiration. Up to 20% of patients with stroke can exhibit\u00a0Cheyne-Stokes respiration. [5] [6] [7]", "contents": "Cheyne Stokes Respirations -- Etiology. Cheyne-Stokes respiration\u00a0is well-studied in patients with heart failure and stroke. In patients with heart failure, male gender, older age, sedentary lifestyle, diagnosis of atrial fibrillation, increased ventricular filling pressure, and more advanced cardiac remodeling are known to\u00a0predispose to\u00a0Cheyne-Stokes respiration. Up to 20% of patients with stroke can exhibit\u00a0Cheyne-Stokes respiration. [5] [6] [7]"}
{"id": "article-19395_6", "title": "Cheyne Stokes Respirations -- Epidemiology", "content": "The true prevalence of\u00a0Cheyne-Stokes respiration\u00a0in the general population is not known and is considered to be rare. Due to varied definitions and modalities of detection used, the incidence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure varies from 25% to 50%. This means that out of nearly 5.7 million patients with heart failure, two to three million patients are expected to have\u00a0Cheyne-Stokes respiration. The incidence is reported to be more in patients with systolic heart failure compared to diastolic heart failure, and\u00a0Cheyne-Stokes respiration\u00a0is also more common in elderly patients.", "contents": "Cheyne Stokes Respirations -- Epidemiology. The true prevalence of\u00a0Cheyne-Stokes respiration\u00a0in the general population is not known and is considered to be rare. Due to varied definitions and modalities of detection used, the incidence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure varies from 25% to 50%. This means that out of nearly 5.7 million patients with heart failure, two to three million patients are expected to have\u00a0Cheyne-Stokes respiration. The incidence is reported to be more in patients with systolic heart failure compared to diastolic heart failure, and\u00a0Cheyne-Stokes respiration\u00a0is also more common in elderly patients."}
{"id": "article-19395_7", "title": "Cheyne Stokes Respirations -- Pathophysiology", "content": "Cheyne-Stokes respiration\u00a0is initiated and maintained due to changes in the apnea threshold and the fluctuating PCO2 levels around this threshold in patients with heart failure or stroke who\u00a0are at risk of unstable central respiratory control. Under normal awake conditions, ventilation is under both cortical and metabolic control. Normal respiration is maintained through the negative feedback mechanism. Peripheral and central chemoreceptors will sense PCO2 levels and trigger either positive with negative reciprocal feedback signals. Normal PCO2 levels are around 45 millimeters of mercury. The highest PCO2 levels to suppress respiration, called apnea threshold, is usually around 4 mm to 6 mm lower than the normal PCO2 levels.\u00a0 The sleep apnea threshold is equal or marginally lower than the aware threshold levels. The difference between these two levels is called carbon dioxide\u00a0reserve. Patients with heart failure are normally tachypneic and maintain lower PCO2 levels, both awake and during sleep. Also, the carbon dioxide reserve in these patients is reduced to 1.3 mm to 3 mm of mercury lower than the resting levels.", "contents": "Cheyne Stokes Respirations -- Pathophysiology. Cheyne-Stokes respiration\u00a0is initiated and maintained due to changes in the apnea threshold and the fluctuating PCO2 levels around this threshold in patients with heart failure or stroke who\u00a0are at risk of unstable central respiratory control. Under normal awake conditions, ventilation is under both cortical and metabolic control. Normal respiration is maintained through the negative feedback mechanism. Peripheral and central chemoreceptors will sense PCO2 levels and trigger either positive with negative reciprocal feedback signals. Normal PCO2 levels are around 45 millimeters of mercury. The highest PCO2 levels to suppress respiration, called apnea threshold, is usually around 4 mm to 6 mm lower than the normal PCO2 levels.\u00a0 The sleep apnea threshold is equal or marginally lower than the aware threshold levels. The difference between these two levels is called carbon dioxide\u00a0reserve. Patients with heart failure are normally tachypneic and maintain lower PCO2 levels, both awake and during sleep. Also, the carbon dioxide reserve in these patients is reduced to 1.3 mm to 3 mm of mercury lower than the resting levels."}
{"id": "article-19395_8", "title": "Cheyne Stokes Respirations -- Pathophysiology", "content": "During transition from awake to non-rapid eye movement (NREM) sleep, cortical control of respiration is progressively diminished, and respiration is dependent on metabolic control based on PCO2 levels. During REM sleep, ventilation is predominately under central control by pontomedullary inspiratory neurons. During the N1 or N2 NREM stage, any unstable respiratory state like arousal or sudden change in sleep stage will result in hyperventilation and a decrease in PCO2 levels. If the PCO2 levels decrease below the already increased apnea threshold levels, central apnea ensues. This slow rise in PCO2 levels will stimulate chemoreceptors and will result in the hyperventilation phase. Due to unstable central control and imprecise feedback support in patients with heart failure and stroke, the PCO2 levels during hyperventilation will fall below the apnea threshold levels,\u00a0 resulting in apnea again. These cycles of apnea and hypercapnia continue, resulting in\u00a0Cheyne-Stokes respiration.", "contents": "Cheyne Stokes Respirations -- Pathophysiology. During transition from awake to non-rapid eye movement (NREM) sleep, cortical control of respiration is progressively diminished, and respiration is dependent on metabolic control based on PCO2 levels. During REM sleep, ventilation is predominately under central control by pontomedullary inspiratory neurons. During the N1 or N2 NREM stage, any unstable respiratory state like arousal or sudden change in sleep stage will result in hyperventilation and a decrease in PCO2 levels. If the PCO2 levels decrease below the already increased apnea threshold levels, central apnea ensues. This slow rise in PCO2 levels will stimulate chemoreceptors and will result in the hyperventilation phase. Due to unstable central control and imprecise feedback support in patients with heart failure and stroke, the PCO2 levels during hyperventilation will fall below the apnea threshold levels,\u00a0 resulting in apnea again. These cycles of apnea and hypercapnia continue, resulting in\u00a0Cheyne-Stokes respiration."}
{"id": "article-19395_9", "title": "Cheyne Stokes Respirations -- History and Physical", "content": "The clinical features of\u00a0Cheyne-Stokes respiration\u00a0are similar to congestive heart failure, including dyspnea, cough, and fatigue. A patient with\u00a0Cheyne-Stokes respiration\u00a0with heart failure shows more lethargy and fatigue due to increased sympathetic activity because of disturbed sleep. Periodic leg movements are more common in patients with heart failure with\u00a0Cheyne-Stokes respiration\u00a0than patients without\u00a0Cheyne-Stokes respiration.", "contents": "Cheyne Stokes Respirations -- History and Physical. The clinical features of\u00a0Cheyne-Stokes respiration\u00a0are similar to congestive heart failure, including dyspnea, cough, and fatigue. A patient with\u00a0Cheyne-Stokes respiration\u00a0with heart failure shows more lethargy and fatigue due to increased sympathetic activity because of disturbed sleep. Periodic leg movements are more common in patients with heart failure with\u00a0Cheyne-Stokes respiration\u00a0than patients without\u00a0Cheyne-Stokes respiration."}
{"id": "article-19395_10", "title": "Cheyne Stokes Respirations -- Evaluation", "content": "Cheyne-Stokes respiration\u00a0is characterized by alternating apnea and hyperventilation during sleep, mostly in the N1 and N2 sleep, and also when awake. This can be clinically observed and documented with a cyclic variation of breathing pattern with a change in saturation from 90% to 100%. Minute ventilation is not routinely monitored during sleep studies. The hyperventilation is documented by rising and falling chest excursions and the tidal volume. If the patient is on a ventilator, then the cyclical change in tidal volume and minute ventilation can be graphed together. The apnea/hyperpnea cycle is around 45 minutes to 75 minutes. This cycle is longer than other causes of central sleep apnea cycle, which typically have a cycle length of 30 to 45 minutes. Cheyne-Stokes respiration\u00a0is worse in the supine position or moving from supine to lateral body position. This type of respiration can be associated with increased blood pressure in patients with type 2 diabetes mellitus. [8]", "contents": "Cheyne Stokes Respirations -- Evaluation. Cheyne-Stokes respiration\u00a0is characterized by alternating apnea and hyperventilation during sleep, mostly in the N1 and N2 sleep, and also when awake. This can be clinically observed and documented with a cyclic variation of breathing pattern with a change in saturation from 90% to 100%. Minute ventilation is not routinely monitored during sleep studies. The hyperventilation is documented by rising and falling chest excursions and the tidal volume. If the patient is on a ventilator, then the cyclical change in tidal volume and minute ventilation can be graphed together. The apnea/hyperpnea cycle is around 45 minutes to 75 minutes. This cycle is longer than other causes of central sleep apnea cycle, which typically have a cycle length of 30 to 45 minutes. Cheyne-Stokes respiration\u00a0is worse in the supine position or moving from supine to lateral body position. This type of respiration can be associated with increased blood pressure in patients with type 2 diabetes mellitus. [8]"}
{"id": "article-19395_11", "title": "Cheyne Stokes Respirations -- Evaluation", "content": "Home sleep apnea testing\u00a0with a type 3 portable monitor can be useful in identifying Cheyne-Stokes respiration and apneic events\u00a0in adults with chronic heart failure. [9]", "contents": "Cheyne Stokes Respirations -- Evaluation. Home sleep apnea testing\u00a0with a type 3 portable monitor can be useful in identifying Cheyne-Stokes respiration and apneic events\u00a0in adults with chronic heart failure. [9]"}
{"id": "article-19395_12", "title": "Cheyne Stokes Respirations -- Treatment / Management", "content": "The main cornerstone of management of\u00a0Cheyne-Stokes respiration\u00a0is optimizing the treatment for the trigger factor, congestive heart failure (CHF), or stroke. The American Academy of Sleep Medicine recommends that positive airway pressure should be considered for all patients with central sleep apnea. The two main modalities of noninvasive treatment for\u00a0Cheyne-Stokes respiration\u00a0are continuous positive airway pressure (CPAP) and adaptive servo-ventilation (ASV). [10] [11] [12]", "contents": "Cheyne Stokes Respirations -- Treatment / Management. The main cornerstone of management of\u00a0Cheyne-Stokes respiration\u00a0is optimizing the treatment for the trigger factor, congestive heart failure (CHF), or stroke. The American Academy of Sleep Medicine recommends that positive airway pressure should be considered for all patients with central sleep apnea. The two main modalities of noninvasive treatment for\u00a0Cheyne-Stokes respiration\u00a0are continuous positive airway pressure (CPAP) and adaptive servo-ventilation (ASV). [10] [11] [12]"}
{"id": "article-19395_13", "title": "Cheyne Stokes Respirations -- Treatment / Management", "content": "CPAP delivers continuous positive pressure and has several mechanisms of action. The positive pressure keeps the upper airway splinted during the central apnea, leading to the stabilization of respiratory drives and improvement in oxygenation and ejection fraction. The positive pressure will also reduce the preload by reducing the venous blood flow to the right atrium and afterload by increasing the intrathoracic pressure, thereby\u00a0improving the ejection fraction. In a clinical trial, CPAP therapy in patients with\u00a0Cheyne-Stokes respiration\u00a0showed improvement in nocturnal desaturation, Left ventricular function, and six-minute walk distance, but there was no improvement in survival.", "contents": "Cheyne Stokes Respirations -- Treatment / Management. CPAP delivers continuous positive pressure and has several mechanisms of action. The positive pressure keeps the upper airway splinted during the central apnea, leading to the stabilization of respiratory drives and improvement in oxygenation and ejection fraction. The positive pressure will also reduce the preload by reducing the venous blood flow to the right atrium and afterload by increasing the intrathoracic pressure, thereby\u00a0improving the ejection fraction. In a clinical trial, CPAP therapy in patients with\u00a0Cheyne-Stokes respiration\u00a0showed improvement in nocturnal desaturation, Left ventricular function, and six-minute walk distance, but there was no improvement in survival."}
{"id": "article-19395_14", "title": "Cheyne Stokes Respirations -- Treatment / Management", "content": "Adaptive servo-ventilation is the newer modality of non-invasive treatment, which is effective and well-tolerated by patients. This mode of noninvasive ventilation can counteract hyperventilation during the hyperpnea phase and prevent hypoventilation during the apnea phase. It delivers constant continuous pressure and can recognize apnea or hypopnea and adjust pressure support with backup ventilation if needed to deliver preset tidal volume. During the hyperventilation phase, the pressure support is reduced, depending on the patient to prevent large tidal volume. Adaptive servo-ventilation is more effective than conventional noninvasive ventilation therapies like continuous positive airway pressure and bilevel positive airway pressure therapy and has been shown to improve the functional class, cardiac functions, exercise capacity, and brain natriuretic peptide (BNP) levels. However, in a recent large clinical trial involving patients with systolic heart failure and\u00a0Cheyne-Stokes respiration\u00a0breathing, the addition of adaptive servo-ventilation to guideline-based medical therapy did not improve outcomes and increased the risk of cardiovascular death.", "contents": "Cheyne Stokes Respirations -- Treatment / Management. Adaptive servo-ventilation is the newer modality of non-invasive treatment, which is effective and well-tolerated by patients. This mode of noninvasive ventilation can counteract hyperventilation during the hyperpnea phase and prevent hypoventilation during the apnea phase. It delivers constant continuous pressure and can recognize apnea or hypopnea and adjust pressure support with backup ventilation if needed to deliver preset tidal volume. During the hyperventilation phase, the pressure support is reduced, depending on the patient to prevent large tidal volume. Adaptive servo-ventilation is more effective than conventional noninvasive ventilation therapies like continuous positive airway pressure and bilevel positive airway pressure therapy and has been shown to improve the functional class, cardiac functions, exercise capacity, and brain natriuretic peptide (BNP) levels. However, in a recent large clinical trial involving patients with systolic heart failure and\u00a0Cheyne-Stokes respiration\u00a0breathing, the addition of adaptive servo-ventilation to guideline-based medical therapy did not improve outcomes and increased the risk of cardiovascular death."}
{"id": "article-19395_15", "title": "Cheyne Stokes Respirations -- Treatment / Management", "content": "There are a few case reports of Theophylline being administered in fatal Cheyne-Stokes respiration with some favorable response. But this drug has to be considered with extreme precautions and is not a permanent solution. [13] [14]", "contents": "Cheyne Stokes Respirations -- Treatment / Management. There are a few case reports of Theophylline being administered in fatal Cheyne-Stokes respiration with some favorable response. But this drug has to be considered with extreme precautions and is not a permanent solution. [13] [14]"}
{"id": "article-19395_16", "title": "Cheyne Stokes Respirations -- Differential Diagnosis", "content": "Cheyne Stokes respiration needs to be differentiated from abnormal respiratory patterns like: [12] Biot breathing Kussmaul respiration Apneustic breathing and Apnea", "contents": "Cheyne Stokes Respirations -- Differential Diagnosis. Cheyne Stokes respiration needs to be differentiated from abnormal respiratory patterns like: [12] Biot breathing Kussmaul respiration Apneustic breathing and Apnea"}
{"id": "article-19395_17", "title": "Cheyne Stokes Respirations -- Prognosis", "content": "The presence of this pattern indicates a bad prognosis unless attended promptly. Cheyne-Stokes respiration in the upright position can be an ominous sign of cardiovascular dysregulation. [15]", "contents": "Cheyne Stokes Respirations -- Prognosis. The presence of this pattern indicates a bad prognosis unless attended promptly. Cheyne-Stokes respiration in the upright position can be an ominous sign of cardiovascular dysregulation. [15]"}
{"id": "article-19395_18", "title": "Cheyne Stokes Respirations -- Complications", "content": "If persisting for a long time, unattended, this type of breathing can lead to CO2 disturbances in the body\u00a0and eventually death.", "contents": "Cheyne Stokes Respirations -- Complications. If persisting for a long time, unattended, this type of breathing can lead to CO2 disturbances in the body\u00a0and eventually death."}
{"id": "article-19395_19", "title": "Cheyne Stokes Respirations -- Deterrence and Patient Education", "content": "The relatives of patients should be educated to notice abnormal breathing patterns in patients with the risk of developing them. Also, they should know about positioning the patients, use of CPAP machines, and breathing exercises.", "contents": "Cheyne Stokes Respirations -- Deterrence and Patient Education. The relatives of patients should be educated to notice abnormal breathing patterns in patients with the risk of developing them. Also, they should know about positioning the patients, use of CPAP machines, and breathing exercises."}
{"id": "article-19395_20", "title": "Cheyne Stokes Respirations -- Pearls and Other Issues", "content": "The repeated interruption in breathing imposes an autonomic, chemical, mechanical, and inflammatory burden on the heart and circulation. The hypoxia during the apnea or hypopnea phase will increase sympathetic activity and myocardial damage. Hypoxia is also known to precipitate rupture of plaques, vasoconstriction of vessels, and promote dementia. Hypercapnia can cause arrhythmia and contribute to lethargy and feeling of fragmented sleep.\u00a0 The presence of\u00a0Cheyne-Stokes respiration\u00a0in a patient with heart failure is a strong independent predictor of cardiac death and hospital readmission. In clinical studies, the presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure is linked to arrhythmia and arrhythmia-related death. Patients with heart failure with\u00a0Cheyne-Stokes respiration\u00a0are more likely to have lower ejection fraction, higher brain natriuretic peptide, and increased plasma catecholamines compared to patients without\u00a0Cheyne-Stokes respiration.", "contents": "Cheyne Stokes Respirations -- Pearls and Other Issues. The repeated interruption in breathing imposes an autonomic, chemical, mechanical, and inflammatory burden on the heart and circulation. The hypoxia during the apnea or hypopnea phase will increase sympathetic activity and myocardial damage. Hypoxia is also known to precipitate rupture of plaques, vasoconstriction of vessels, and promote dementia. Hypercapnia can cause arrhythmia and contribute to lethargy and feeling of fragmented sleep.\u00a0 The presence of\u00a0Cheyne-Stokes respiration\u00a0in a patient with heart failure is a strong independent predictor of cardiac death and hospital readmission. In clinical studies, the presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure is linked to arrhythmia and arrhythmia-related death. Patients with heart failure with\u00a0Cheyne-Stokes respiration\u00a0are more likely to have lower ejection fraction, higher brain natriuretic peptide, and increased plasma catecholamines compared to patients without\u00a0Cheyne-Stokes respiration."}
{"id": "article-19395_21", "title": "Cheyne Stokes Respirations -- Pearls and Other Issues", "content": "Cheyne-Stokes respiration\u00a0is a complex breathing disorder seen in patients with heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0affects the overall prognosis of patients with heart failure.\u00a0 Although the exact pathophysiology of\u00a0Cheyne-Stokes respiration\u00a0is still not clear, the latest development in noninvasive therapy offers hope for a potential cure. Further research is needed to understand and treat this disorder precisely.", "contents": "Cheyne Stokes Respirations -- Pearls and Other Issues. Cheyne-Stokes respiration\u00a0is a complex breathing disorder seen in patients with heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0affects the overall prognosis of patients with heart failure.\u00a0 Although the exact pathophysiology of\u00a0Cheyne-Stokes respiration\u00a0is still not clear, the latest development in noninvasive therapy offers hope for a potential cure. Further research is needed to understand and treat this disorder precisely."}
{"id": "article-19395_22", "title": "Cheyne Stokes Respirations -- Enhancing Healthcare Team Outcomes", "content": "The management of patients with heart failure is done by an interprofessional team. One of the complications of heart failure is Cheyne-Stokes breathing.\u00a0Cheyne-Stokes respiration is a type of\u00a0breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Unlike obstructive sleep apnea (OSA), which can be the cause of heart failure, Cheyne-Stokes respiration\u00a0is believed to be a result of heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure also predicts worse outcomes and increases the risk of sudden cardiac death. Despite increasing recognition and growing knowledge,\u00a0Cheyne-Stokes respiration\u00a0remains elusive, and patients have very limited treatment options. These patients are best managed by a cardiologist, pulmonologist, heart failure specialist, intensivist, and cardiology nurses. With no ideal treatment, the prognosis for these patients is guarded.", "contents": "Cheyne Stokes Respirations -- Enhancing Healthcare Team Outcomes. The management of patients with heart failure is done by an interprofessional team. One of the complications of heart failure is Cheyne-Stokes breathing.\u00a0Cheyne-Stokes respiration is a type of\u00a0breathing disorder characterized by cyclical episodes of apnea and hyperventilation. Although described in the early 19th century by John Cheyne and William Stokes, this disorder has received considerable attention in the last decade due to its association with heart failure and stroke, two major causes of mortality, and morbidity in developed countries. Unlike obstructive sleep apnea (OSA), which can be the cause of heart failure, Cheyne-Stokes respiration\u00a0is believed to be a result of heart failure. The presence of\u00a0Cheyne-Stokes respiration\u00a0in patients with heart failure also predicts worse outcomes and increases the risk of sudden cardiac death. Despite increasing recognition and growing knowledge,\u00a0Cheyne-Stokes respiration\u00a0remains elusive, and patients have very limited treatment options. These patients are best managed by a cardiologist, pulmonologist, heart failure specialist, intensivist, and cardiology nurses. With no ideal treatment, the prognosis for these patients is guarded."}
{"id": "article-19395_23", "title": "Cheyne Stokes Respirations -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cheyne Stokes Respirations -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}